Furthermore, it has been demonstrated that the peroxisomal branched-chain fatty acid oxidation pathway is upregulated in PCa [29] and that the peroxisomal membrane protein PMP34 [30] and the peroxisomal β-oxidation enzyme DECR2 [28] contribute to treatment resistance in advanced PCa. Here, SLC25A17 is linked to posterior cortical atrophy.